Mr. Andre Larente reports

DIAGNOS ANNOUNCES FINANCIAL CONTRIBUTION OF $400,000 FROM THE GOVERNMENT OF CANADA

Diagnos Inc. was granted a financial contribution of up to $400,000 from the Canada Economic Development for Quebec Regions Organization (CED) to implement an international marketing strategy for CARA (the project).

As per the terms of the financial assistance agreement signed between Diagnos and CED, CED has committed to making a refundable contribution up to $400,000 to Diagnos, calculated at 50 per cent of eligible expenses related to the project, for the period of June 7, 2024, to June 30, 2026. Repayment of the contribution by Diagnos will begin 24 months after the end of the project and span over 60 months, no interest bearing.

Andre Larente, president and chief executive officer of Diagnos, said: "We would like to thank CED for its support and trust in Diagnos. We are proud to be recognized by the government of Canada as being a key asset in the Canadian economy."

More details are available in the press release from CED, dated Jan. 29, 2025, which can be found on-line.

About Diagnos Inc.

Diagnos is a publicly traded Canadian corporation dedicated to early detection of critical health problems based on its Flaire artificial intelligence (AI) platform. Flaire allows for quick modifying and developing of applications such as CARA (computer-assisted retina analysis). CARA's image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a cost-effective tool for real-time screening of large volumes of patients.

We seek Safe Harbor.